Option chain shows key data for Galera Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Galera Therapeutics.

Galera Therapeutics (OTC:GRTX) Stock, Option Chain

Galera Therapeutics

Galera Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. The Firm's lead product candidate, avasopasem manganese, is a highly selective small molecule dismutase mimetic for severe oral mucositis (SOM) in patients with head and neck cancer (HNC), the reduction of esophagitis in patients with lung cancer, and the reduction of cisplatin-induced kidney damage in patients with cancer. The Firm's second product candidate, rucosopasem manganese, has been in development to augment the anti-cancer efficacy of stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer (NSCLC) and locally advanced pancreatic cancer (LAPC).

Movers

News

Intraday Update

Markets

Trading Ideas

ADRT

ADSK

AFMD

BNAI

BPTH

CAMP

CGON

CNSP

COHR

CRKN

DELL

DHAC

DOGZ

DRCT

EFSH

FFIE

FOXO

GPCR

GRTX

IMCR

IPDN

ISPC

LQDA

LSCC

MBOT

MGNX

MOLN

NVAX

OLMA

Grupo Aeroportuario del Centro NorteB de CV

OMAB

PGEN

PRTG

PSNL

SAIC

SRCL

Vintage Wine Estates, Inc. - Common Stock

WBUY

YGMZ

Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

stock-market-6693060

Galera Therapeutics shares are trading lower by 34.8% during Monday&#39;s session. The company said its shares will be delisted due to non-compliance with Nasdaq&#39;s continued listing standards.

Why Galera Therapeutics (GRTX) Stock Is Nosediving

Penny Stocks

Small Cap

Pre-Market Outlook

APLT

AVTX

CLSK

CURV

DOMA

GUTS

MCAF

MDIA

NDRA

PAVM

SBFM

SINT

VSTE

VVOS

XTKG

ZPTA

Shares of  Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash.

Doma Holdings shares jumped 34.1% to $6.09 in pre-market trading

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket

GALERA THERAPEUTICS INC by Galera Therapeutics, Inc.

Galera Therapeutics Inc

A recent study <a href="https://www.nature.com/articles/s41598-024-79931-w">published</a> in Scientific Reports explores the strategies individuals use to navigate challenging psychedelic experiences and how these responses relate to emotional breakthroughs. Researchers from University College London conducted a mixed-methods investigation, combining qualitative analyses of <a href="https://www.benzinga.com/topic/psilocybin">psilocybin</a> retreat participants&#8217; experiences with a broader survey involving 529 individuals who reported past psychedelic use.
<h3 class="wp-block-heading">Three Core Strategies Identified</h3>
The study developed the Responses to Challenging Psychedelic Experiences Inventory (ReCiPE), revealing three key coping strategies:
<ul>
<li>Acceptance and Reappraisal: Emphasizing surrender and acceptance of the experience, this approach was most strongly associated with emotional breakthroughs.</li>
<li>Sensory Regulation and Physical Interaction: Strategies such as intentional breathing, movement or environmental engagement helped participants manage distress.</li>
<li>Social Support and Disclosure: Seeking help or sharing experiences with others proved beneficial, reinforcing the role of interpersonal dynamics during challenging moments.</li>
</ul>
<h3 class="wp-block-heading">Fear Vs. Breakthroughs</h3>
The research found that not all challenges led to positive outcomes. Fear-related experiences often hindered emotional breakthroughs, whereas grief and death-related challenges were more likely to result in transformative insights. This suggests that the type of distress experienced during a psychedelic session plays a significant role in determining therapeutic outcomes. 
See also: <a href="https://www.benzinga.com/markets/cannabis/23/06/32800473/psychedelic-trip-dos-and-donts-what-to-avoid-during-your-psychedelic-experience">Psychedelic Trip Do&#8217;s And Don&#8217;ts: What To Avoid During Your Psychedelic Experience</a>
<h3 class="wp-block-heading">Implications For Psychedelic-Assisted Therapy</h3>
The findings highlight the importance of equipping individuals with adaptive coping strategies, particularly through acceptance-based approaches such as mindfulness or Acceptance and Commitment Therapy. Tailored interventions that address fear and promote cognitive reappraisal could enhance the safety and efficacy of <a href="https://www.benzinga.com/topic/psychedelic-assisted-therapies">psychedelic-assisted therapies</a>.
As the study authors conclude, "The paradoxical positive therapeutic role of challenging psychedelic experiences may depend on the kind of challenge faced and the individual's ability to employ adaptive response strategies."
Cover image made with AI

Cannabis

Psychedelics

How To Navigate Difficult Psychedelic Journeys: Research Insights

WIIM

UPXI

Upexi shares are trading higher. The company announced it received a Non Compliance letter from the Nasdaq.

Investors with a lot of money to spend have taken a bullish stance on Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ALAB, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Astera Labs.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 37%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $104,790, and 5 are calls, for a total amount of $588,530.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $90.0 to $110.0 for Astera Labs during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Astera Labs's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Astera Labs's significant trades, within a strike price range of $90.0 to $110.0, over the past month.
<h3>Astera Labs 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732303890_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$11.7</td>
<td>$10.6</td>
<td>$11.3</td>
<td>$110.00</td>
<td>$394.3K</td>
<td>1.8K</td>
<td>2.1K</td>
</tr>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$8.5</td>
<td>$8.1</td>
<td>$8.2</td>
<td>$105.00</td>
<td>$64.7K</td>
<td>1.6K</td>
<td>295</td>
</tr>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$10.2</td>
<td>$10.0</td>
<td>$10.1</td>
<td>$110.00</td>
<td>$50.5K</td>
<td>1.8K</td>
<td>2.2K</td>
</tr>
<tr>
<td>ALAB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$21.3</td>
<td>$20.6</td>
<td>$20.6</td>
<td>$90.00</td>
<td>$49.4K</td>
<td>2.2K</td>
<td>35</td>
</tr>
<tr>
<td>ALAB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$7.1</td>
<td>$7.0</td>
<td>$7.0</td>
<td>$105.00</td>
<td>$35.0K</td>
<td>246</td>
<td>120</td>
</tr>
</tbody>
</table>

<h3>About Astera Labs</h3>
Astera Labs Inc is a company that offers an Intelligent Connectivity Platform, comprised of Semiconductor-based, high-speed mixed-signal connectivity products that integrate a matrix of microcontrollers and sensors. COSMOS, their software suite which is embedded in its connectivity products and integrated into their customers' systems. The Company delivers critical connectivity performance, enables flexibility and customization, and supports observability and predictive analytics. This approach addresses the data, network, and memory bottlenecks, scalability, and other infrastructure requirements of hyperscalers and system original equipment manufacturers.
After a thorough review of the options trading surrounding Astera Labs, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Astera Labs Standing Right Now?</h3>
<ul>
<li>With a trading volume of 2,309,533, the price of ALAB is up by 1.1%, reaching $105.27.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 122 days from now.</li>
</ul>
<h3>Expert Opinions on Astera Labs</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $101.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Deutsche Bank keeps a Buy rating on Astera Labs with a target price of $100. 
&#x2A; An analyst from Citigroup downgraded its action to Buy with a price target of $120. 
&#x2A; Maintaining their stance, an analyst from Craig-Hallum continues to hold a Buy rating for Astera Labs, targeting a price of $105. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Astera Labs, which currently sits at a price target of $87. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Astera Labs, which currently sits at a price target of $94. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Astera Labs options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

ALAB

Astera Labs Options Trading: A Deep Dive into Market Sentiment

Whales with a lot of money to spend have taken a noticeably bearish stance on NIO.
Looking at options history for NIO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) we detected 22 trades.
If we consider the specifics of each trade, it is accurate to state that 4% of the investors opened trades with bullish expectations and 90% with bearish.
From the overall spotted trades, 17 are puts, for a total amount of $1,002,691 and 5, calls, for a total amount of $164,560.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $4.0 and $20.0 for NIO, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for NIO's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of NIO's whale activity within a strike price range from $4.0 to $20.0 in the last 30 days. 
<h3>NIO Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732303885_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NIO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.0</td>
<td>$3.9</td>
<td>$3.95</td>
<td>$8.00</td>
<td>$129.1K</td>
<td>17.6K</td>
<td>881</td>
</tr>
<tr>
<td>NIO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.95</td>
<td>$3.85</td>
<td>$3.95</td>
<td>$8.00</td>
<td>$83.6K</td>
<td>17.6K</td>
<td>3.9K</td>
</tr>
<tr>
<td>NIO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.95</td>
<td>$3.9</td>
<td>$3.95</td>
<td>$8.00</td>
<td>$78.9K</td>
<td>17.6K</td>
<td>1.8K</td>
</tr>
<tr>
<td>NIO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.95</td>
<td>$3.9</td>
<td>$3.92</td>
<td>$8.00</td>
<td>$68.8K</td>
<td>17.6K</td>
<td>1.5K</td>
</tr>
<tr>
<td>NIO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$0.67</td>
<td>$0.65</td>
<td>$0.67</td>
<td>$5.00</td>
<td>$67.0K</td>
<td>63.0K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About NIO</h3>
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold over 160,000 EVs in 2023, accounting for about 2% of the China passenger new energy vehicle market.
In light of the recent options history for NIO, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is NIO Standing Right Now?</h3>
<ul>
<li>With a volume of 45,538,092, the price of NIO is up 3.4% at $4.86. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 102 days.</li>
</ul>
<h3>What The Experts Say On NIO</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $5.699999999999999.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Macquarie has revised its rating downward to Neutral, adjusting the price target to $4. 
&#x2A; An analyst from Macquarie has elevated its stance to Outperform, setting a new price target at $6. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest NIO options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

NIO Unusual Options Activity For November 22

Whales with a lot of money to spend have taken a noticeably bearish stance on United Airlines Holdings.
Looking at options history for United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) we detected 18 trades.
If we consider the specifics of each trade, it is accurate to state that 27% of the investors opened trades with bullish expectations and 44% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $235,826 and 11, calls, for a total amount of $525,405.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $40.0 to $130.0 for United Airlines Holdings during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for United Airlines Holdings's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of United Airlines Holdings's whale activity within a strike price range from $40.0 to $130.0 in the last 30 days. 
<h3>United Airlines Holdings Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732303880_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$21.2</td>
<td>$19.1</td>
<td>$21.2</td>
<td>$92.50</td>
<td>$169.6K</td>
<td>7</td>
<td align="right">81</td>
</tr>
<tr>
<td>UAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$35.75</td>
<td>$35.45</td>
<td>$35.75</td>
<td>$60.00</td>
<td>$53.6K</td>
<td>2.7K</td>
<td align="right">27</td>
</tr>
<tr>
<td>UAL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$13.2</td>
<td>$13.1</td>
<td>$13.1</td>
<td>$95.00</td>
<td>$44.5K</td>
<td>646</td>
<td align="right">0</td>
</tr>
<tr>
<td>UAL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$1.94</td>
<td>$1.42</td>
<td>$1.94</td>
<td>$94.00</td>
<td>$38.8K</td>
<td>599</td>
<td align="right">288</td>
</tr>
<tr>
<td>UAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$25.3</td>
<td>$24.95</td>
<td>$25.25</td>
<td>$75.00</td>
<td>$37.8K</td>
<td>2.1K</td>
<td align="right">48</td>
</tr>
</tbody>
</table>

<h3>About United Airlines Holdings</h3>
United Airlines is a major us network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel than its large us peers.
Following our analysis of the options activities associated with United Airlines Holdings, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of United Airlines Holdings</h3>
<ul>
<li>Trading volume stands at 4,166,913, with UAL's price down by -0.79%, positioned at $93.65.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 60 days.</li>
</ul>
<h3>Professional Analyst Ratings for United Airlines Holdings</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $131.33333333333334.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on United Airlines Holdings, which currently sits at a price target of $150. 
&#x2A; Reflecting concerns, an analyst from Goldman Sachs lowers its rating to Buy with a new price target of $119. 
&#x2A; An analyst from TD Cowen persists with their Buy rating on United Airlines Holdings, maintaining a target price of $125. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest United Airlines Holdings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Check Out What Whales Are Doing With UAL

<a href="https://news.alaskaair.com/destinations/alaska-airlines-unveils-top-fall-travel-trends-and-unique-destinations/" title="https://news.alaskaair.com/destinations/alaska-airlines-unveils-top-fall-travel-trends-and-unique-destinations/">https://news.alaskaair.com/destinations/alaska-airlines-unveils-top-fall-travel-trends-and-unique-destinations/</a>

Events

Alaska Air Group Says "Thanksgiving Remains The Busiest Travel Period Of The Fall With Flights Projected To Be Nearly Full. We Estimate Nearly 500K Guests Will Fly Between Friday And Sunday With Dec. 1 Expected To Be The Busiest Day Of The Entire Year. Across Our Major West Coast Hubs, We Expect To Fly More Passengers Than Last Year"

<a href="https://www.n-tv.de/politik/Stehen-kurz-vor-Loesung-mit-China-um-Zoelle-abzuschaffen-article25381322.html" title="https://www.n-tv.de/politik/Stehen-kurz-vor-Loesung-mit-China-um-Zoelle-abzuschaffen-article25381322.html">https://www.n-tv.de/politik/Stehen-kurz-vor-Loesung-mit-China-um-Zoelle-abzuschaffen-article25381322.html</a>

Macro Economic Events

Global

Economics

XPEV

Chair Of European Parliament Trade Committee Tells German Broadcaster NTV, "We Are Close To Agreement With China To Abolish Electric Vehicle Import Tariffs"

October was a strong month for the gaming industry, with eight of the top ten best-selling games in the <a href="https://www.benzinga.com/topic/video-games">U.S. being new releases</a>.
Call of Duty: Black Ops 6 topped the charts, contributing to a 10% year-over-year increase in U.S. video game spending, which reached $4.7 billion.
According to Circana&#8217;s monthly report (<a href="https://www.ign.com/articles/october-2024-sales-charts-call-of-duty-black-ops-6-sparks-xbox-game-pass-subscription-surge">via</a> IGN), Black Ops 6 is already the third best-selling game of the year and saw sales 23% higher in its first two weeks than last year's Modern Warfare 3 over the same period. 
See Also:<a href="https://www.benzinga.com/general/gaming/24/11/42141838/elden-ring-creator-hidetaka-miyazaki-teases-various-new-projects-in-development"> Elden Ring Creator Hidetaka Miyazaki Teases &#8216;Various New Projects&#8217; In Development</a>
Mat Piscatella of Circana noted that 82% of the game's full dollar sales came from PlayStation 5, likely because Xbox players opted to access the game through Game Pass instead of purchasing it outright.
<h3 class="wp-block-heading">Game Pass And Subscription Growth</h3>
The availability of <a href="https://www.benzinga.com/general/gaming/24/10/41662426/black-ops-6-shatters-records-call-of-dutys-biggest-launch-drives-60-sales-spike">Black Ops 6 on Game Pass</a> appears to have driven growth in video game subscription spending, which increased 16% year-over-year in October. 
This suggests that the game attracted new subscribers to Microsoft Corp.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) platform while maintaining strong sales elsewhere.
<h3 class="wp-block-heading">Dragon Ball And Silent Hill Stand Out</h3>
Dragon Ball: Sparking! Zero secured the second spot on October's sales charts and became the best-selling Dragon Ball game in the U.S. The game is also now the third best-selling title in Bandai Namco Holdings ADR&#8217;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NCBDY#OTC">NCBDY</a>) history, following<a href="https://www.benzinga.com/general/gaming/24/11/42068231/sony-in-talks-to-acquire-elden-ring-publisher-kadokawa-report"> Elden Ring </a>and Dark Souls 3.
The Silent Hill 2 remake came in third and is now the second best-selling game in the franchise, second only to the original Silent Hill 2.
<h3 class="wp-block-heading">Sales Shifts from Discounts and Game Pass</h3>
The Final Fantasy I-VI Collection moved up from No. 90 in September to No. 19 in October, likely due to a significant price drop on Nintendo ADR&#8216;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NTDOY#OTC">NTDOY</a>) Nintendo Switch. Meanwhile, Sifu climbed to No. 9 on Xbox's monthly active users chart after being added to Game Pass.
<h3 class="wp-block-heading">Hardware And Accessories Performance</h3>
Hardware sales saw a 23% decline compared to last year. Nintendo Switch sales dropped 38%, while PlayStation 5 and Xbox Series sales were down 20% and 18%, respectively. The PlayStation 5 remains the top-selling console in both units and dollar sales, with Xbox Series consoles in second place.
In accessories, spending increased by 15%, with Sony Group Corp's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) PlayStation Portal becoming the month's best-selling item.
<h3 class="wp-block-heading">Top 20 Best-Selling Games In October</h3>
<ol>
<li>Call of Duty: Black Ops 6</li>
<li>Dragon Ball: Sparking! Zero</li>
<li>Silent Hill 2</li>
<li>Undisputed</li>
<li>Metaphor: ReFantazio</li>
<li>Dragon Age: The Veilguard</li>
<li>Super Mario Party Jamboree!&#x2A;</li>
<li>Madden NFL 25</li>
<li>Sonic X Shadow Generations</li>
<li>EA Sports FC 25</li>
<li>EA Sports College Football 25</li>
<li>The Legend of Zelda: Echoes of Wisdom&#x2A;</li>
<li>Hogwarts Legacy</li>
<li>NHL 25</li>
<li>Astro Bot</li>
<li>Minecraft&#x2A;</li>
<li>NBA 2K25</li>
<li>Life Is Strange: Double Exposure</li>
<li>Final Fantasy I-VI Bundle</li>
<li>Elden Ring</li>
</ol>
(&#x2A;Digital sales data for some titles are not included in Circana's report.)
As the year approaches its final months, upcoming Black Friday deals may impact both hardware and software sales.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/11/42144628/gta-6-trailer-2-fans-frustrated-as-rockstar-possibly-breaks-moon-theory">GTA 6 Trailer 2 Fans Frustrated As Rockstar Possibly Breaks Moon Theory</a></li>
</ul>
Image credits: Shutterstock.

MSFT

NCBDY

NTDOY

Sony Group Corporation American Depositary Shares

SONY

Call Of Duty: Black Ops 6 Leads Video Game October Sales In The US

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining by more than 350 points on Friday.
The Dow traded up 0.82% to 44,228.50 while the NASDAQ rose 0.14% to 18,998.27. The S&amp;P 500 also rose, gaining, 0.31% to 5,966.91.
Check This Out: <a href="https://www.benzinga.com/24/11/42135346/top-3-materials-stocks-that-could-blast-off-in-november">Top 3 Materials Stocks That Could Blast Off In November</a>
Leading and Lagging Sectors Consumer staples shares rose by 1.5% on Friday.
In trading on Friday, communication services shares fell by 0.6%.
Top Headline
Shares of Intuit Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) fell over 5% on Friday after the company reported upbeat results for its first-quarter results, but issued weak forecast for the current quarter.
The company reported quarterly earnings of $2.50 per share, which beat the analyst consensus estimate of $2.35 per share. Quarterly revenue came in at $3.28 billion which beat the consensus estimate of $3.14 billion
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Elastic N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) shares shot up 16% to $109.17 after the company reported better-than-expected second-quarter financial results and issued FY25 guidance above estimates.</li>
<li>Shares of Matthews International Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATW#NASDAQ">MATW</a>) got a boost, surging 19% to $30.26 following upbeat earnings.</li>
<li>Replimune Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REPL#NASDAQ">REPL</a>) shares were also up, gaining 45% to $16.00 after the company on Thursday announced it received breakthrough therapy designation status for RP1 and will submit an RP1 biologics license application to the FDA under an accelerated approval pathway.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Autonomix Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) shares dropped 55% to $6.11 after the company announced the pricing of a $9 million underwritten public offering.</li>
<li>Shares of Aptose Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APTO#NASDAQ">APTO</a>) were down 43% to $0.1390 after the company announced the pricing of an $8 million public offering.</li>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) was down, falling 41% to $0.1164 after the company announced its board approved a 1-for-35 reverse stock split.</li>
</ul>
Commodities In commodity news, oil traded up 1.5% to $71.16 while gold traded up 1.1% at $2,704.00.
Silver traded up 1.1% to $31.275 on Friday, while copper fell 0.8% to $4.0940.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 1.12%, Germany's DAX gained 0.77% and France's CAC 40 rose 0.46%. Spain's IBEX 35 Index rose 0.16%, while London's FTSE 100 gained 1.35%.
The S&amp;P Global UK composite PMI declined to 49.9 in November versus 51.8 in the previous month, while Eurozone composite PMI dipped to 48.1 in November from 50 in the prior month.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 gaining 0.68%, Hong Kong's Hang Seng Index falling 1.89%, China's Shanghai Composite Index dipping 3.06% and India's BSE Sensex gaining 2.54%.
Economics
<ul>
<li>The S&amp;P Global US Services PMI climbed to 57 in November versus 55 in the previous month, while manufacturing PMI increased to 48.8 in November from 48.5 in the previous month.</li>
<li>The University of Michigan consumer sentiment for the US fell to 71.8 in November versus a preliminary reading of 73.</li>
<li>The year-ahead inflation expectations in the U.S fell to 2.6% in November from 2.7% in October.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/24/11/42135946/wall-streets-most-accurate-analysts-give-their-take-on-3-industrials-stocks-with-over-3-dividend-yields-3">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Industrials Stocks With Over 3% Dividend Yields</a>

Earnings

Analyst Ratings

AMIX

APTO

CETX

ESTC

INTU

MATW

REPL

S&P 500 Moves Higher; Intuit Shares Fall Following Q1 Results

KSCP

Knightscope shares are trading lower after the company announced a proposed public offering of Class A common stock and pre-funded warrants to address working capital needs.

Medtronic's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) short percent of float has fallen 4.76% since its last report. The company recently reported that it has 10.18 million shares sold short, which is 0.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.93 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Medtronic Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732302924_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Medtronic has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Medtronic's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Medtronic's peer group average for short interest as a percentage of float is 4.17%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Medtronic's Recent Short Interest

UP Fintech Holding's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NYSE">TIGR</a>) short percent of float has fallen 25.28% since its last report. The company recently reported that it has 6.07 million shares sold short, which is 4.73% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>UP Fintech Holding Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732302919_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for UP Fintech Holding has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing UP Fintech Holding's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, UP Fintech Holding's peer group average for short interest as a percentage of float is 2.77%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

TIGR

Looking Into UP Fintech Holding's Recent Short Interest

DuPont de Nemours's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) short percent of float has risen 3.03% since its last report. The company recently reported that it has 3.76 million shares sold short, which is 1.02% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.73 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>DuPont de Nemours Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732302913_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for DuPont de Nemours has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing DuPont de Nemours's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, DuPont de Nemours's peer group average for short interest as a percentage of float is 3.19%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into DuPont de Nemours's Recent Short Interest

SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) shares are trading higher on Friday. The company announced the deployment of its conversational AI agent, Amelia at Apivia Courtage, as part of the AEMA Group. Here&#8217;s <a href="https://www.benzinga.com/quote/SOUN/news">what you need to know.</a>
What To Know: In a press release on Thursday, SoundHound AI reported that Amelia AI agents managed over 100,000 customer calls in 2024, reducing the volume of inbound queries handled by human employees at Apivia Courtage by nearly 20%. These calls were largely focused on medical expense reimbursements and insurance policy information. The deployment, which began in Jan. 2023, was designed to improve efficiency and allow customer service teams to focus on higher-value tasks.
The CEO of Apivia Courtage, Emmanuelle Nguyen, stated that integrating the AI system enhanced work quality for employees and improved workplace atmosphere. Michael Anderson, EVP of Enterprise at SoundHound AI, emphasized the benefits of automation in enabling contact center staff to manage more complex tasks.
&#8220;With AI agents managing routine customer questions, Apivia Courtage&#8217;s employees are now able to focus on more rewarding and valuable aspects of their work. We&#8217;re thrilled to support them in delivering thousands of high-quality interactions,&#8221; commented Anderson.
Apivia Courtage, operating under the AEMA Group, is one of France&#8217;s largest insurance entities, serving over 11 million customers through more than 1,600 agencies and 3,900 brokers. The group&#8217;s annual revenue exceeds €15 billion.
&#8220;Projects like this really show the incredible value AI and automation can deliver, not only to our customers but also to their customers,&#8221; said Anderson.
SOUN Price Action: SoundHound AI shares were up 20.6% at $8.41 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="532" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22133150/OSUNS-1024x532.png" alt="" class="wp-image-661538" style="width:453px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22133150/OSUNS-1024x532.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22133150/OSUNS-300x156.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22133150/OSUNS-768x399.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22133150/OSUNS.png 1162w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Image Via Shutterstock.

SOUN

SoundHound AI Shares Are On The Rise Friday: What's Going On?

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PDD Holdings shares are trading lower after JP Morgan downgraded the stock from Overweight to Neutral and lowered the price target from $170 to $105.

Celestica shares are trading lower after UBS initiated coverage on the stock with a Neutral rating and announced a price target of $95.

Best Buy shares are trading higher after JP Morgan maintained an Overweight rating on the stock and raised its price target from $111 to $117.

DOCU

DocuSign shares are trading higher after JMP Securities maintained a Market Outperform rating on the stock and raised its price target from $84 to $108.

CRNC

Cerence shares are trading higher after Craig-Halum maintained a Hold rating on the stock and raised its price target from $3.5 to $6.

ALLY

Ally Financial shares are trading higher after the company announced it's assessing the potential sale of its credit card business.

Galera Therapeutics GAAP EPS of -$0.10

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday!



Moving stocks this morning are earnings reports, acquisition plans, new drug data and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>INVO Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/invo-stock-quote/">INVO</a>) stock is rocketing more than 55% alongside its <a href="https://finance.yahoo.com/news/invo-reports-fourth-quarter-full-205900118.html">Q4 earnings report</a>.</li>



<li>Vanda Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/vnda-stock-quote/">VNDA</a>) shares are soaring over 38% on <a href="https://www.nasdaq.com/press-release/future-pak-confirms-proposal-to-acquire-vanda-pharmaceuticals-for-%247.25-to-%247.75-per">a firm acquisition proposal</a>.</li>



<li>VIA Optronics (NYSE:<a href="https://investorplace.com/stock-quotes/viao-stock-quote/">VIAO</a>) stock is surging more than 32% with heavy pre-market trading.</li>



<li>Clene (NASDAQ:<a href="https://investorplace.com/stock-quotes/clnn-stock-quote/">CLNN</a>) shares are rising over 26% on <a href="https://seekingalpha.com/news/4090283-clene-stock-rallies-post-market-on-ms-drug-data?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain%7Csection%3Aon-the-move">new drug data</a>.</li>



<li>Chromocell Therapeutics (NYSEMKT:<a href="https://investorplace.com/stock-quotes/chro-stock-quote/">CHRO</a>) stock is gaining more than 26% on an update to a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318239123&amp;type=PDF&amp;symbol=CHRO&amp;cdn=722216dc7f57070dff83767fe9648f9d&amp;companyName=Chromocell+Therapeutics+Corporation&amp;formType=424B3&amp;formDescription=Prospectus+%5BRule+424%28b%29%283%29%5D&amp;dateFiled=2024-04-17">secondary stock offering</a>.</li>



<li>CXApp (NASDAQ:<a href="https://investorplace.com/stock-quotes/cxai-stock-quote/">CXAI</a>) shares are increasing over 26% with its <a href="https://www.marketwatch.com/story/cxapp-shares-rise-29-on-4q-2023-annual-recurring-revenue-growth-13f8abea">latest earnings report</a>.</li>



<li>Seelos Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/seel-stock-quote/">SEEL</a>) stock is climbing more than 24% without any clear news on Wednesday morning.</li>



<li>Mobile Global Esports (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgam-stock-quote/">MGAM</a>) shares are getting a 22% boost as it <a href="https://investorplace.com/2024/04/why-is-mobile-global-esports-mgam-stock-down-18-today/">prepares for delisting</a>.</li>



<li>Gamer Pakistan (NASDAQ:<a href="https://investorplace.com/stock-quotes/gpak-stock-quote/">GPAK</a>) stock is jumping 21% despite a lack of news today.</li>



<li>Galera Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/grtx-stock-quote/">GRTX</a>) shares are up over 19% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318238318&amp;type=PDF&amp;symbol=GRTX&amp;cdn=6788b7c94daccbdc9a6c5412e270d44c&amp;companyName=Galera+Therapeutics+Inc.&amp;formType=SC+13G&amp;formDescription=Statement+of+acquisition+of+beneficial+ownership+by+individuals&amp;dateFiled=2024-04-16">shareholder stake update</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Trilogy Metals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tmq-stock-quote/">TMQ</a>) stock is plummeting more than 22% <a href="https://www.nasdaq.com/press-release/trilogy-metals-provides-update-on-the-ambler-access-project-2024-04-17">following an update</a> to its Ambler Access Project.</li>



<li>Trio Petroleum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tpet-stock-quote/">TPET</a>) shares are diving over 20% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318239194&amp;type=PDF&amp;symbol=TPET&amp;cdn=fb7a5495a316777660288b1087458323&amp;companyName=Trio+Petroleum+Corp.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-17">securing senior notes and a purchase agreement</a>.</li>



<li>Connexa Sports Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/yyai-stock-quote/">YYAI</a>) stock is tumbling more than 18% on Wednesday morning.</li>



<li>Destiny Tech100 (NYSE:<a href="https://investorplace.com/stock-quotes/dxyz-stock-quote/">DXYZ</a>) shares are taking a close to 18% beating following a rally yesterday.</li>



<li>Ontrak (NASDAQ:<a href="https://investorplace.com/stock-quotes/otrk-stock-quote/">OTRK</a>) stock is sliding over 16% with the release of its <a href="https://finance.yahoo.com/news/ontrak-announces-2023-fourth-quarter-200500612.html">Q4 2023 earnings report</a>.</li>



<li>Dragonfly Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/dfli-stock-quote/">DFLI</a>) shares are retreating more than 16% <a href="https://investorplace.com/2024/04/why-is-dragonfly-energy-dfli-stock-up-56-today/">after rallying yesterday</a>.</li>



<li>Dynatronics (NASDAQ:<a href="https://investorplace.com/stock-quotes/dynt-stock-quote/">DYNT</a>) stock is pulling back over 16% <a href="https://investorplace.com/2024/04/why-is-dynatronics-dynt-stock-up-93-today/">after rising on Tuesday</a>.</li>



<li>Ryvyl (NASDAQ:<a href="https://investorplace.com/stock-quotes/rvyl-stock-quote/">RVYL</a>) shares are still falling more than 15% despite <a href="https://www.nasdaq.com/press-release/ryvyl-inc.-announces-cancellation-of-proposed-underwritten-public-offering-2024-04-16">canceling a proposed public offering</a>.</li>



<li>Hub Cyber Security (NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/">HUBC</a>) stock is dropping over 14% <a href="https://investorplace.com/2024/04/why-is-hub-cyber-security-hubc-stock-up-35-today/">after a rally yesterday</a>.</li>



<li>iSun (NASDAQ:<a href="https://investorplace.com/stock-quotes/isun-stock-quote/">ISUN</a>) shares close out our pre-market stock movers down more than 13% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318238741&amp;type=PDF&amp;symbol=ISUN&amp;cdn=82f25393dbc89b776256155c3f0856b7&amp;companyName=iSun+Inc.&amp;formType=10-K&amp;formDescription=Annual+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-16">on an investor update</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-april-17th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start off the trading week with a look at the biggest pre-market stock movers for Monday morning!



Moving stocks this morning are earnings, investments, a delisting and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Moolec Science (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlec-stock-quote/">MLEC</a>) stock is rocketing more than 67% on approval for its <a href="https://www.nasdaq.com/press-release/moolec-becomes-first-molecular-farming-company-to-achieve-usda-approval-for-plant">plant-groan animal proteins</a>.</li>



<li>OLB Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/olb-stock-quote/">OLB</a>) shares are soaring over 46% with heavy pre-market trading.</li>



<li>Complete Solaria (NASDAQ:<a href="https://investorplace.com/stock-quotes/cslr-stock-quote/">CSLR</a>) stock is surging more than 42% <a href="https://www.nasdaq.com/press-release/retail-stock-sector-and-chairman-t.j.-rodgers-invest-in-complete-solaria-2024-04-21">on investment news</a>.</li>



<li>SuperCom (NASDAQ:<a href="https://investorplace.com/stock-quotes/spcb-stock-quote/">SPCB</a>) shares are gaining over 33% ahead of its <a href="https://www.nasdaq.com/press-release/supercom-to-report-fourth-quarter-and-full-year-2023-financial-results-on-april-22">Q4 2023 earnings report</a> this morning.</li>



<li>Dermata Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/drma-stock-quote/">DRMA</a>) stock is rising more than 18% on Monday morning.</li>



<li>Galera Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/grtx-stock-quote/">GRTX</a>) shares are increasing over 17% without any clear news this morning.</li>



<li>Palisade Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/pali-stock-quote/">PALI</a>) stock is climbing more than 16% despite a lack of news today.</li>



<li>Global Gas (NASDAQ:<a href="https://investorplace.com/stock-quotes/hgas-stock-quote/">HGAS</a>) shares are heading over 14% higher on Monday.</li>



<li>Volato (NYSEMKT:<a href="https://investorplace.com/stock-quotes/soar-stock-quote/">SOAR</a>) stock is jumping more than 13% on Monday morning.</li>



<li>Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) shares are up over 13% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Vaxxinity (NASDAQ:<a href="https://investorplace.com/stock-quotes/vaxx-stock-quote/">VAXX</a>) stock is crashing more than 55% on the company&rsquo;s <a href="https://finance.yahoo.com/news/vaxxinity-announces-intention-voluntarily-delist-202700884.html">plans to delist its shares</a>.</li>



<li>EzFill (NASDAQ:<a href="https://investorplace.com/stock-quotes/ezfl-stock-quote/">EZFL</a>) shares are plummeting close to 37% this morning.</li>



<li>Hepion Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/hepa-stock-quote/">HEPA</a>) stock is diving over 29% on plans to <a href="https://www.nasdaq.com/press-release/hepion-pharmaceuticals-initiates-wind-down-activities-in-phase-2b-ascend-nash-trial">wind down a clinical trial</a>.</li>



<li>iLearningEngines (NASDAQ:<a href="https://investorplace.com/stock-quotes/aile-stock-quote/">AILE</a>) shares are tumbling more than 21% after <a href="https://finance.yahoo.com/news/ilearningengines-inc-becomes-publicly-traded-200500132.html">going public last week</a>.</li>



<li>Redwoods Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/rwod-stock-quote/">RWOD</a>) stock is taking an over 15% beating <a href="https://investorplace.com/2024/04/why-is-redwoods-acquisition-rwod-stock-up-72-today/">after a recent rally</a>.</li>



<li>Biophytis (NASDAQ:<a href="https://investorplace.com/stock-quotes/bpts-stock-quote/">BPTS</a>) shares are sliding more than 15% ahead of <a href="https://www.nasdaq.com/press-release/biophytis-announces-ratio-change-under-its-american-depositary-receipt-adr-program-0">a ratio change tomorrow</a>.</li>



<li>Adlai Nortye (NASDAQ:<a href="https://investorplace.com/stock-quotes/anl-stock-quote/">ANL</a>) stock is dropping nearly 15% today.</li>



<li>BioSig Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/bsgm-stock-quote/">BSGM</a>) shares are falling over 13% this morning.</li>



<li>Sunshine Biopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/sbfm-stock-quote/">SBFM</a>) stock is decreasing more than 12% today.</li>



<li>Indonesia Energy (NYSEMKT:<a href="https://investorplace.com/stock-quotes/indo-stock-quote/">INDO</a>) shares close out our pre-market stock movers down over 10%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-april-22nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Galera Therapeutics (GRTX) has issued an update. Galera Therapeutics, Inc. has implemented a stockholder rights plan, issuing one Right per common ...

Galera Therapeutics Enacts Plan to Deter Hostile Takeovers

Galera Therapeutics GAAP EPS of -$0.08

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Galera Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/grtx-stock-quote/">GRTX</a>) just reported results for the first quarter of 2024.<ul><li>Galera Therapeutics reported earnings per share of -8 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/grtx-stock-earnings-galera-therapeutics-for-q1-of-2024/">GRTX Stock Earnings: Galera Therapeutics Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

GRTX Stock Earnings: Galera Therapeutics Reported Results for Q1 2024

Galera Therapeutics (GRTX) has provided an update. Galera Therapeutics, Inc. is streamlining its operations amidst a strategic review by eliminatin...

Galera Therapeutics Restructures Leadership and Cuts Costs

Galera Therapeutics (GRTX) just unveiled an announcement. Galera Therapeutics, Inc. recently settled a lawsuit against two Clinical Research Organi...

Galera Therapeutics Settles Clinical Trial Dispute Lawsuit

Galera Therapeutics (GRTX) has shared an update. Galera is set to dissolve and wind up its business, a decision made by the Board to benefit the sh...

Galera Therapeutics Announces Wind-Up and Special Stockholder Meeting

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Galera Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/grtx-stock-quote/">GRTX</a>) just reported results for the second quarter of 2024.<ul><li>Galera Therapeutics reported earnings per share of -7 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/grtx-stock-earnings-galera-therapeutics-for-q2-of-2024/">GRTX Stock Earnings: Galera Therapeutics Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

GRTX Stock Earnings: Galera Therapeutics Reported Results for Q2 2024

AILE

BPTS

BSGM

CHRO

CLNN

CSLR

CXAI

DFLI

DRMA

DXYZ

DYNT

EZFL

GPAK

HEPA

HGAS

HUBC

INDO

INVO

ISUN

MGAM

MLEC

OTRK

PALI

RVYL

RWOD

SEEL

SOAR

SPCB

TPET

VAXX

VIAO

VNDA

YYAI

Biotech

Press Releases

General

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates

Galera Adopts Limited Duration Stockholder Rights Agreement

Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates

Galera Announces Board Approval of Complete Liquidation and Dissolution

Citigroup

Comments

Galera Therapeutics

Galera Therapeutics (GRTX) Options

Galera Therapeutics (OTC:GRTX) Stock, Option Chain

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga